Team Nicola MARCHI – Étienne AUDINAT
Cerebrovascular and Glia Research


We examine cells within the neurovascular unit in the context of central nervous system diseases. Through translational research, we explore how neurovascular cells’ responsiveness and adaptability and the blood-brain barrier’s permeability influence neuroinflammation, exacerbating changes in neuronal function over time. Our approach integrates in vivo and in vitro laboratory studies with clinical investigations to understand the underlying mechanisms and assess peripheral blood biomarkers associated with dysfunction in the neurovascular unit.
Glio-vascular cell reactivity in experimental and human focal and genetic epilepsies. This framework is relevant for cases where seizures cannot be adequately controlled with anti-seizure medications or where, regardless of drug responsiveness, side effects must be minimized. We integrate cellular-level and neurophysiological tools, in vitro and preclinical models (including status epilepticus, temporal lobe epilepsy, and Dravet syndrome), and the analysis of surgically resected human brain tissue to investigate the role of glial cell reactivity and blood-brain barrier damage in the pathophysiology of these seizure conditions. We explore opportunities for novel targets and the discovery of blood or imaging biomarkers to improve patient management. Our research also examines the contribution of seizures to neurological deficits and neurodegeneration in the aging population.
Neurovascular damage and immune communications in human stroke. The goal of our research is to identify specific molecular and biomarker signatures that can inform the development of add-on therapeutic options, which would target key inflammatory pathways in conjunction with mechanical thrombectomy. By focusing on these inflammatory pathways, we aim to not only enhance the effectiveness of mechanical thrombectomy but also reduce the risk of post-procedural complications and improve patient outcomes. Our clinical team leverages mechanical thrombectomy procedures to obtain intracranial clot and peri-clot blood samples. These samples are analyzed to characterize the inflammatory milieu within the affected tissue and surrounding vasculature. This enables us to improve our understanding of the molecular et cellular mechanisms involved.
Environmental contaminants and xenobiotics at brain borders: risk factors of neuro-inflammation and neuro-vascular frailty. The impact of exposure to environmental pollutants or xenobiotics on neuro-glio-vascular structures and cells remains unclear. We investigate the effects of long-term, age-related exposure to contaminants at realistic doses on CNS functions and peripheral organs. Given that perinatal inflammation, primarily driven by the reactivity of glial and vascular cells, is a known risk factor for the development of neurological and psychiatric disorders, a critical aspect of our project is to evaluate the consequences of contaminant exposure (pesticides, bisphenol and others) during embryonic and postnatal development on glia and cerebrovascular cells in adulthood.

The Neurovascular Unit: A Nexus in CNS Diseases and Maladaptation. At the NVU, the blood-brain barrier (BBB) consists of a tight endothelial-pericyte-astrocyte end-feet assembly. In response to acute insults or chronic conditions (peripheral or brain), BBB permeability increases with pericyte and glial cell reactivity. These events contribute to a loss of parenchymal homeostasis and facilitate aberrant synaptic transmission, thereby representing a risk factor for negative neurological sequelae and brain frailty.



-
1988PhD Neuroscience - Pierre & Marie Curie University - Paris - France
-
1985Master Degree - Neuroscience - Pierre & Marie Curie University - Paris - France
-
1983Bachelor Degree - Cellular Biology & Physiology-University of Grenoble - France
-
2018-Research Director at CNRS - Institut de Génomique Fonctionnelle - Montpellier - France
-
2005-2017Research Director at CNRS - Université Paris Descartes - France
-
2001-2004Research Director at CNRS - ESPCI - Paris - France
-
1995-2000Research Associate at CNRS - ESPCI - Paris - France
-
1991-1994Research Associate at CNRS - Université de Paris Sud - Orsay - France
-
1989-1990Postdoc - Brain Research Institute - Zürich - Switzerland
-
1985-1988PhD Student - Université Paris Sud - Orsay - France
-
2019-Head of the Neuroscience department at IGF
-
2014-2023Chair of the Scientific Council of the French Foundation for Research on Epilepsy (FFRE)
-
2020-2022Chair of the Steering Committee of the French Network (GDR) "Microglia & Neuroinflammation"
-
2014-2017Member of the Scientific Council of the Federation of Brain Research (FRC)
-
2014Medical Research Foundation (FRM) Team Award
-
2011-2014Vice-president of the evaluation commission "Habilitation to Direct Research" (HDR) of the University of Paris Descartes
-
2011-2013General Secretary of the French Society for Neuroscience
-
2009-2013Member of the Scientific Council of the French Society for Neuroscience
-
2004-2008Member of the CNRS study section "Physiology"
-
2001Inserm Avenir Team Award
- Combining electrophysiology (patch-clamp, EEG), optogenetics and cellular imaging (2-photon, miniscope) ex vivo and in vivo, I study how glial cells (astrocytes and microglia) interact and influence neurons during brain development and in mouse models of epilepsy.



-
2005-2008PostDoctoral Fellow - Department of Neurosurgery - Lerner Research Institute, Cleveland Clinic - USA
-
2003-2005PostDoctoral Fellow - Department of Neuroscience - Mario Negri Pharmacological Institute - Milan - Italy
-
2001-2003PostDoctoral Fellow - Department of Neurosurgery - Lerner Research Institute - Cleveland Clinic - USA
-
2000Doctoral Degree - School of Pharmacy and Pharmaceutical Chemistry - University of Pisa - Italy
-
2024-CNRS Researcher (CRHC) - Institute of Functional Genomics (IGF) - Montpellier - France
-
2013-2023 CNRS Researcher (CRCN) - Institute of Functional Genomics (IGF) - Montpellier - France
-
2013-Adjunct Staff and Assist. Professor - Cleveland Clinic Lerner College of Medicine - Case Western Reserve University - USA
-
2010-2013Assistant Professor - Cleveland Clinic Lerner College of Medicine - Case Western Reserve University - Cleveland Clinic - USA
-
2008-2013Project Scientist - Staff - Lerner Research Institute - Cleveland Clinic - USA
-
2020-Epilepsia Open, Associate Editor (International League Against Epilepsy, ILAE)
-
2020-2024Epilepsia, Editorial Board
-
2011Insigna at the International League against Epilepsy (Rome, ILAE)
-
2008The Morris-Coole Award - World Wide Award (ILAE Symposium for Excellence in Epilepsy, Berlin, Germany)
-
2008Innovator Award (Cleveland Clinic) - "Anakinra reduces status epilepticus"
-
2005Young Investigator Award - International League Against Epilepsy (ILAE), Paris, France
-
2012-2018NIH RO1 Principal Investigator - Drug brain biotransformation in human refractory epilepsy
-
2016-Teaching, Master Neuroscience, University of Montpellier, France
-
2016-University Diploma of Epileptology - University Hospital CHRU La Timone, Marseille, France
-
2009-2013Member of the Cleveland Clinic Lerner College of Medicine Admission Committee - candidate interview and evaluation
-
2009-2013American Heart Association (AHA): Study Section Brain
-
2008-Reviewer for several international journals, national and international funding agencies (not listed)
- My translational research studies neurovascular unit (NVU) dysfunction, brain-barrier damage, and inflammation in brain disorders and during environmental challenges. With my Team, I investigate how the loss of neurovascular integrity intertwines with neuronal dysfunctions and neuroinflammation. We study peripheral or brain-derived bio-fluid biomarkers and develop in vitro 3D flow-based systems to model the glio-vasculature. We study the NVU as a target to limit the onset of brain vulnerabilities in translational settings.












-
2012Bachelor in Science - Analytical and Experimental Biology - Univ. Montpellier - France
-
2011DU - Biological Engineering Technology, specializing in Biological and Biochemical Analysis - Univ. Montpellier - France
-
2017-Technician in Biology (permanent position), "Cerebrovascular and Glial Research" team - Institut de Génomique Fonctionnelle - Montpellier - France
-
2013-2017Laboratory technician (fixed-term contract), "Skeletal muscle dysfunction in acquired and hereditary diseases" team - INSERM PhyMedExp - Montpellier - France
-
2023-IGF prevention assistant appointed by the University of Montpellier
-
2021-2025Elected representative on the IGF Laboratory Council for the ITA college
- Human (primary or immortalized) and animal cell culture: purification of target cells, amplification, transfection, quantification by flow cytometry.
- Molecular biology and biochemistry: protein extraction and assay using Western Blot and ELISA techniques, Luminex or MesoScale quantification kits, RNA extraction, gene expression quantification using RT-qPCR, quality control using BioAgilent chips.
- Histology: sectioning by vibratome or cryostat, labeling of target proteins on cells or tissues, imaging and analysis by fluorescence microscopy.







- Bachelor: Degree of Biology- Department of Biology-University of Ioannina-Greece
- Master: Ecology Master- Department of Biology-University of Ioannina-Greece
- Ph.D. : PhD: Assessment of the effects of chemical agents with environmental impact using the model organismzebrafish (Danio rerio)-University of Ioannina
- 2015-2016: Research Associate-Instute of Fisheries Research Institute-Kavala-Greece
- 2016-2022: Research Associate-University of Ioannina-Greece
- 2022-2023: Post doc Researcher-University of Ioannina-Greece
- 2023-now: Post doc Researcher- IGF Montpellier- CNRS-France
- Ecotoxicology, zebrafish, Behavioral analysis, environmental implications, pollution







-
2022-PhD student - Doctoral School ED168, Chemical and Biological Sciences for Health (CBS2), University of Montpellier - France
-
2020-2022Master's degree in Biology and Health, Neuroscience cursus (M1: 1/20 and M2: 1/27) - University of Montpellier - France
-
2018-2020Licence Animal Physiology Animale & Neurosciences (L2 : 6/433 et L3 : 1/139) - University of Montpellier - France
-
2016-2018DUT Biological Engineering, Food and Biological Industries option, University of Lyon 1 - Bourg en Bresse - France
-
2016Scientific Baccalaureate, specializing in Earth Sciences, GOOD mention, dance-study course at the Avignon Conservatory - France
-
2022-Thesis, Institute of Functional Genomics - Montpellier - France
-
2022-2023Biology teacher (64 hours), BUT Génie Biologique - Univ. Montpellier - France
-
2022CNRS engineer (1-month fixed-term contract), Institute of Functional Genomics - Montpellier - France
-
2018Virology laboratory technician (3-month fixed-term contract), Centre Hospitalier Henri Duffaut - Avignon - France
-
2022PhD fellowship from Doctoral School ED168 - Chemical and Biological Sciences for Health (CBS2) (Ranking: 1/80)
- Laboratory Techniques
- Bacteriology
- PCR
- Spinal dorsal root ganglia (DRG) cultures
- Calcium imaging on DRG culture
- Immunohistochemistry
- Electrophysiology coupled with optogenetics on hippocampal slices
- Designer training level 1 & surgery
- Data analysis
- GraphPad Prism
- Mastery of Pack office
- Image J










-
2014PhD - Molecular and Translational Medicine - University of Milan - Italy
-
2009Master's degree - Biology - University of Milan - Italy
-
2021-Research engineer - Institute of Functional Genomics - Montpellier - France
-
2018-2021Postdoctoral fellow - Humanitas Research Hospital - Milan - Italy
-
2015-2018Postdoctoral fellow - Université Paris Descartes - Paris - France
-
2010-2014PhD student - Besta Neurological Institute - Milan - Italy
- Main techniques
- Immunohistochemical procedures for light, fluorescent and confocal microscopy
- Electrophysiology
- Live cell imaging (biosensors)
- Behavioral analyses (Open field test, Marble Burying test, Self-grooming test, Prepulse inhibition of startle response test, Light/Dark Chamber, Three chamber social preference test, Rotarod test, Grip and Grid test)
- Analysis of electroencephalographic tracings
- Level 1 designer and surgery training
- Data analysis
- GraphPad Prism
- Image J
- Pack office
- Ponemah and Neuroscore
- Clampfit and Origin












- Nicole Pinzon-Hoyos, Yibo Li, Monnie McGee, Nicholas P Poolos, Nicola Marchi, Amy L Brewster. Drug-resistant epilepsy associated with peripheral complement decreases and sex-specific cytokine imbalances: a pilot study. Scientific Report, in press 2025
- Cyril Dargazanli#, Marine Blaquière , Marinette Moynier , Frédéric de Bock , Julien Labreuche, Adrien Ter Schiphorst, Imad Derraz, Răzvan Alexandru Radu, Gregory Gascou, Pierre Henri Lefevre, Francesca Rapido, Julien Fendeleur, Caroline Arquizan, Romain Bourcier, Philippe Marin, Paolo Machi, Federico Cagnazzo, Christophe Hirtz, Vincent Costalat#, Nicola Marchi#. Inflammation biomarkers in the intracranial blood are associated with outcome in patients with ischemic stroke. J Neurointerv Surg 2025 Jan 17;17(2):159-166. doi: 10.1136/jnis-2023-021365.
- V. Costalat et. al. Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size. N Engl J Med 2024 May 9;390(18):1677-1689. doi: 10.1056/NEJMoa2314063.
- Noemie Cresto, Laurent Givalois, Jerome Badaut, Alicia Janvier, Athenais Genin, Etienne Audinat, Amy L Brewster, Nicola Marchi Bursts of brain erosion: Seizures and age-dependent neurological vulnerability. Trends in Molecular Medicine, Dec, 2024
- Noemie Cresto, Margot Courret, Athénaïs Génin, Céline Marie, Pauline Martin, Julie Bourret, Sophie Sakkaki, Frederic de Bock, Alicia Janvier, Arnaud Polizzi, Laurence Payrastre, Sandrine Ellero-Simatos, Etienne Audinat, Julie Perroy, Nicola Marchi. Continuous low-level dietary exposure to glyphosate elicits dose and sex-dependent synaptic and microglial adaptations in the rodent brain. Environmental Pollution Volume 345, 15 March 2024, 123477
- Garcia V*, Blaquiere M*, Janvier A, Cresto N, Lana C, Genin A, Hirbec H, Audinat E, Faucherre A, Barbier EL, Hamelin S, Kahane P, Jopling C, Marchi PIEZO1 expression at the glio-vascular unit adjusts to neuroinflammation in seizure conditions. Neurobiology of Disease 2023. doi.org/10.1016/j.nbd.2023.106297.
- Erwin vanVliet and Nicola Marchi. Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging. Epilepsia 2022. https://doi.org/10.1111/epi.17210
- Canet G, Zub E, Zussy C, Hernandez C, Blaquiere M, Garcia V, Vitalis M, DeBock F, Moreno-Montano M, Audinat E, Desrumaux C, Planel E, Givalois L, Marchi N. Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways. Epilepsia 2022. doi: 10.1111/epi.17186
- Paolicelli RC et al., Microglia states and nomenclature: A field at its crossroads. Neuron 2022 10(21): 3458-3483 doi: 10.1016/j.neuron.2022.10.020
- Forner-Piquer I, Faucherre A, Byram J, Blaquiere M, de Bock F, Gamet-Payrastre L, Ellero-Simatos S, Audinat E, Jopling C, Marchi N. Differential impact of dose-range glyphosate on locomotor behavior, neuronal activity, glio-cerebrovascular structures, and transcript regulations in zebrafish larvae. Chemosphere 2021 267:128986. doi: 10.1016/j.chemosphere.2020.128986.
- Thion MS*, Mosser CA*, Ferezou I, Grisel P, Baptista S, Low D, Ginhoux F, Garel S*, Audinat E*. Biphasic impact of prenatal inflammation and microglia depletion on the wiring of neocortical inhibitory circuits. Cell Reports 2019 30;28(5):1119-1126.e4. doi: 10.1016/j.celrep.2019.06.086
Mechanisms of neurovascular damage and inflammation due to large vessel occlusion (V. Costalat, C. Dargazanli, A. Ter-Schiphorst, F. Cagnazzo, E. LeBars, CHU Montpellier/IGF). We investigate brain and systemic inflammatory or biomarker signatures in post-ischemic stroke using cardio-embolic and atherosclerotic human clots and intracranial blood samples. We aim to improve patient management and offer add-on therapeutic option along with mechanical thrombectomy. We study mechanisms of idiopathic intracranial hyper- or hypo-tension. Find out more
Analysis of explanted intracranial electrodes in drug-resistant epilepsy as a source of intracranial biological traces (Prof. Bartolomei, J. Scholly, S. Lagarde, CHU La Timone, Marseille). The goal is to isolate a nano-scale quantity of RNA or protein derived from the intracranial tissue environment where the depth electrode resided during the pre-surgical exploration of seizure networks. To overlap these innovative biological data with those obtained by imaging and SEEG to establish a map of the molecular physiological connections in the epileptic brain. Find out more
Neurovascular damage and inflammatory cross-talk in psychiatric conditions: focus on depression and suicide attempts (P. Courtet, E. Olie, R. Belzeaux; CHU/IGF). The goal is to discover outcome protein biomarkers in blood and to develop an add-on therapeutic option based on the modulation of specific inflammatory players.
- Garel (ENS Paris), N. Rouach (Collège de France, Paris) : Microglia in the wiring of Inhibitory circuits during sensory cortex critical periods (MicroSenso) ; ANR-19-CE16-0018
- Rassendren and P. Mollard teams (IGF) : Deciphering ATP Signaling in Epilepsy with Biosensors (Diapason) ; ANR-20-CE16-0003.
- Levi (IFM, Paris), D. Blum (Lille Neuroscience & Cognition), C. Bernard (INS Marseille) : The Janus-faced Impact of caffeine in the developing and the ageing brain: role of synaptic remodeling (JANUS) ; ANR-21-CE14-0053.
- Hirbec (Rassendren team, IGF), G. Dorothée (Saint Antoine Research Center, Paris), V. Navarro (Salpêtrière Hospital & Paris Brain Institute, Paris) : tRreg protection of seizure propagation zones In temPoral Lobe EpilepsY (RIPLEY) ; ANR-23-CE14-0052.
- Tronche (Neuroscience Paris Seine), D. Blum (Lille Neuroscience & Cognition) : Stress signaling in microglia: behavioral, functional, and molecular consequences (MicroGlioStress) : ANR-23-CE14-0010.
- Collaboration with J. Perroy (IGF), ANR-Glyphore: impact of dietary glyphosate on brain functions.
- Collaboration with C. Jopling (IGF), ANSES OptoFish: examines the impact of environmental contaminats using zebrafish models.